Related Experiment Video
Updated: Aug 9, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Perinatal management of congenital diaphragmatic hernia
Andrea F Conforti1, Paul D Losty
1Department of Paediatric Surgery, The Royal Liverpool Children's Hospital (Alder Hey) Division of Child Health, University of Liverpool, United Kingdom.
Insights
Congenital diaphragmatic hernia (CDH) is a severe birth defect with high mortality. Advances in perinatal management, including gentle ventilation, aim to improve survival rates for affected infants.
Area of Science:
- Perinatal Medicine
- Developmental Biology
- Pediatric Surgery
Background:
- Congenital diaphragmatic hernia (CDH) is associated with significant mortality, primarily due to lung hypoplasia and pulmonary hypertension.
- Current management strategies focus on improving survival and outcomes through various interventions.
Purpose of the Study:
- To highlight clinical trends in the perinatal management of congenital diaphragmatic hernia (CDH).
- To discuss advancements in therapy and ongoing research for CDH.
Main Methods:
- Review of current clinical trends in CDH management.
- Discussion of therapeutic advances such as permissive hypercapnia ('gentle ventilation').
- Mention of ongoing human genetic studies and basic science research.
Main Results:
- Permissive hypercapnia ('gentle ventilation') is gaining wider acceptance globally as a therapeutic advance.
- Fetal intervention, specialized delivery, and optimized surgical timing are key management components.
- Genetic and developmental biology research holds promise for understanding CDH etiology.
Conclusions:
- Optimized perinatal management, including gentle ventilation, is crucial for improving CDH outcomes.
- Continued research in genetics and developmental biology is essential for uncovering fundamental aspects of CDH.
- Addressing the challenges of CDH requires a multidisciplinary approach and ongoing innovation in clinical practice.
Abstract:
Congenital diaphragmatic hernia (CDH) retains high mortality due to lung hypoplasia and pulmonary hypertension. Efforts to improve survival and outcome have included fetal intervention, delivery at specialist centres, elective operation after stabilisation of labile physiology and minimising barotrauma. Permissive hypercapnea ('gentle ventilation') represents a significant advance in therapy gaining wider acceptance in centres worldwide. Human genetic studies are underway to identify candidate genes for the birth defect. Progress in the basic sciences may uncover critical aspects of developmental biology fundamental to CDH. Clinical trends in perinatal management of CDH are highlighted, which underpin the challenges of this lethal human anomaly.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Mitral Valve Prolapse III: Nursing Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Mitral Stenosis IV: Nursing Management
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Mitral Regurgitation IV: Nursing Management
